We are delighted to invite you to this 15th Thoracic Oncology Winter Symposium on 19 January 2019.
We have selected a programme which deals with some of the latest developments in thoracic oncology: screening, stereotactic radiotherapy of brain met’s and immunotherapy in special conditions.
This annual symposium offers a unique opportunity to hear the opinion of (inter) national experts in thoracic oncology.
Don’t miss this great meeting in magnificent downtown Antwerp!
We look forward to greeting you in Antwerp next year
Prof. Dr. Veerle Surmont
Prof. Dr. Jan van Meerbeeck
Chair Department of Pulmonology
Saturday, 19 January 2019
BNP Paribas Fortis Antwerpen,
Auditorium Hélène Fourment, entrance via Wapper,
in front of Rubens’ house 2000, Antwerpen
Click here for a route description.
Please note the entrance of the meeting venue is via ‘Wapper’ left around the corner if you are on the Meir in front of the building.
More information can be found on: www.parkereninantwerpen.be/parkeermogelijkheden
Parking garages near Wapper:
Parking Hopland, Hopland 38-40
Parking Horta, Hopland 24
Parking Inno, Hopland 45
Parking Stadsschouwburg, Meistraat 4
09.30 Welcome and introduction
Jan van Meerbeeck, UZ Antwerp
Session 1: Lung cancer screening
Chairs: Annemie Snoeckx (UZ Antwerp) & Veerle Surmont (UZ Ghent)
09.35 NELSON: the Trafalgar of lung cancer screening? – Harry de Koning (Erasmus MC, Rotterdam, NL)
09.55 Lung cancer screening in Belgium: quo vadis? – Kristiaan Nackaerts (UZ Leuven)
Session 2: Targeting brain metastases: Stereotactic Radiosurgery will replace Whole Brain Radiotherapy
Chairs: Yolande Lievens (UZ Ghent) & Annelies Janssens (UZ Antwerp)
10.10 Against the motion – Jean François Daisne (CHU-UCL-Namur , BE)
10.30 In favour of the motion – Matthias Guckenberger (Zürich, CH)
10.50 Voting session – Thomas Malfait (UZ Ghent)
11.00 Coffee break
Session 3: Update in systemic therapy of lung cancer
Chairs: Paul Van Schil (UZ Antwerp) & Karim Vermaelen (UZ Ghent)
11.30 Is there still a role for surgery in the era of immunotherapy? – Joshua Sonett (New York, USA)
12.00 Consolidation I/O in stage 3: not so PACIFIC? – Corey Langer (Philadelphia, USA)
12.30 Targeted and immunotherapy in SCLC and thymoma – Giuseppe Giaccone (Georgetown, USA)
13.00 Summary – Veerle Surmont (UZ Ghent)
13.10 Walking lunch
Accredited with RIZIV/INAMI is pending, last year 3.5 E&E points. The NVALT has accredited the meeting with 3 points.
This symposium will be of special interest for pulmonologists, radiation oncologists, thoracic surgeons, medical oncologists, radiologists, pathologists, and investigators interested in thoracic oncology.
Please register on-line via the button above.
Registration fee is EUR 60 (EUR 40 for ASO’s), and is including admission to the meeting, programme/abstract book, break, lunch buffet and certificate of attendance.
Written cancellations received before Friday, 4 January 2019 will be refunded less EUR 15 administration costs.